Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Traditional Chinese medicine preparation for treating heat-toxicity heart-disoperation type viral myocarditis

A technology for viral myocarditis and traditional Chinese medicine preparations, applied in antiviral agents, cardiovascular system diseases, medical preparations containing active ingredients, etc., can solve problems such as inconvenience, achieve high yield, nourish myocardium, reduce clinical use effect of dose

Inactive Publication Date: 2012-11-14
李佃场
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The technical problem to be solved by the present invention is to provide a traditional Chinese medicine preparation for treating heat-toxin-invading heart-type viral myocarditis and its preparation method. There are still many deficiencies in the current medicines for treating heat-toxin-invading heart-type viral myocarditis. Chemotherapy is still the main treatment, the treatment cycle is long, the side effects are large, the curative effect is not accurate, and it is not easy to persist. Oral decoction is used, and there is no traditional Chinese medicine injection form. For oral dosage forms, not only the body absorbs the drug slowly, but also it is inconvenient to use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine preparation for treating heat-toxicity heart-disoperation type viral myocarditis
  • Traditional Chinese medicine preparation for treating heat-toxicity heart-disoperation type viral myocarditis

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0055] The preparation method of tablet of the present invention: Ophiopogon japonicus 1500g, salvia miltiorrhiza 1200g, safflower 1000g, red peony 1500g, schisandra chinensis 1500g, astragalus 1500g, wulingzhi 1500g, atractylodes atractylodes 1500g, loofah 1500g, chuanxiong 1500g, curcuma 1500g, scutellaria baicalensis 1500g, Polygala 1000g, Angelica 1500g, Radix Radix 1100g, Folium Isatidis 1100g, Honeysuckle 1100g, Forsythia 1100g, Peppermint 1500g, Gardenia 1500g, Panax notoginseng 1500g, Earthworm 1500g plus 10 times the amount of ethanol, heated and refluxed for 3 times, each time 2 After 1 hour, the three extracts were combined, the ethanol was recovered under reduced pressure and concentrated to a concentration of 0.5 g crude drug / mL. After suction filtration, the relative density of the filtrate was about 1.08 (20° C.); Pore ​​adsorption resin column, first eluted with deionized water or distilled water 10 times the volume of the resin column, then eluted with 95% etha...

experiment example 1

[0058] Experimental example 1: acute toxicity test of the present invention

[0059] 1. Test materials:

[0060] Animals: Kunming mice, weighing 21-24g, half male and half male, bred by Huake Biological Laboratory. Medicine: tablet of the present invention, containing 0.0425g crude drug / sheet.

[0061] 2. Method:

[0062] 1. Calculation of LD50: Using the improved Cole's method, the mice were randomly divided into 5 groups, 10 in each group, half male and half male, and the tablet was dissolved in distilled water to make the maximum concentration, and administered according to the maximum allowable volume of the mice. Dosing is followed by 18, 14.4, 11.5, 9.2, 7.4 (g.kg-1) according to the crude drug amount, and after the animal is fasted (can't help water) for 18 hours, it is divided into two administrations (interval half an hour) in one day, 0.5ml each time, observe the animal death.

[0063] 2. Determination of maximum tolerated dose (MTD value): take 20 mice, 10 males...

experiment example 2

[0066] Experimental example 2: Acute toxicity and long-term toxicity test results

[0067] Acute toxicity test: give drop pill of the present invention by intragastric administration of mice, maximum concentration 35%, maximum intragastric capacity 0.4ml / 10g, dosage 14g / kg (every g of medicinal powder is equivalent to 10g crude drug), observe continuously 7 days, No toxic reaction was found, and the LD 50 of the drug could not be measured because the concentration and dose could not be increased. Determination of the maximum tolerated dose: with the highest concentration and the maximum gavage volume, the mice were gavaged three times with an interval of 5 hours, and then observed continuously for 7 days, and no case died. The dosage of the medicinal powder is >42g / kg.day (each g of medicinal powder is equivalent to 10g of crude drug), which is equivalent to 420 times of the clinical daily dosage of an adult in terms of kilogram body weight. Long-term toxicity test: In order ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a traditional Chinese medicine preparation for treating heat-toxicity heart-disoperation type viral myocarditis. The traditional Chinese medicine preparation comprises the following medicinal raw materials in parts by weight: 10-20 parts of radix ophiopogonis, 10-20 parts of the root of red-rooted salvia, 10-20 parts of carthamus tinctorius, 10-20 parts of root of common peony, 10-20 parts of schisandra chinensis, 10-20 parts of pseudo-ginseng, 10-20 parts of astragalus mongholicus, 10-20 parts of trogopterus dung, 10-20 parts of rhizoma atractylodis, 10-20 parts of vegetable sponge, 10-20 parts of ligusticum wallichii, 10-20 parts of curcuma zedoary, 10-20 parts of scutellaria baicalensis, 10-20 parts of polygala tenuifolia, 10-20 parts of lumbricus, 10-20 parts of angelica sinensis, 10-20 parts of isatis root, 10-20 parts of folium isatidis, 10-20 parts of honeysuckle, 10-20 parts of fructus forsythiae, 10-20 parts of mint, and 10-20 parts of cape jasmine. The traditional Chinese medicine preparation disclosed by the invention is capable of rapidly in-flowing blood, directly achieving myocardium, rapidly increasing myocardial contraction force, tonifying qi, nourishing yin, invigorating blood circulation, removing stasis, calming the mind, soothing the liver and reducing heat and has the main functions of detoxifying, removing stasis, clearing heat, opening the inhibited lung-energy and clearing away the heart-fire; therefore, the function of rapidly relieving patient conditions can be achieved.

Description

technical field [0001] The invention relates to a medical preparation containing components derived from plants, animals or minerals, in particular to a traditional Chinese medicine preparation for treating viral myocarditis of heat-toxin-invading heart type. Background technique [0002] Viral myocarditis is the most common type of myocarditis with the largest number of patients in clinical practice. It is endemic. The incidence rate has increased by more than 10 times compared with 10 years ago. It has become the most common cardiomyopathy in my country. At that time, about 5% of patients caused viral myocarditis during the epidemic period of viral infection. In recent years, the understanding of viral myocarditis has continued to deepen. There are many viruses that can cause myocarditis, such as: Coxsackie virus, adenovirus, influenza virus, etc. Among them, the myocarditis caused by Coxsackie virus group B is the most common, because the myocardium is particularly sensit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61K9/20A61K9/48A61P31/12A61P9/00
Inventor 李佃场梁轶聪王漪
Owner 李佃场
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products